Earum Pharmaceuticals net loss reported at Rs 0.72 crore in quarter ended March 2022 vs. net loss of Rs 0.99 crore in previous quarter ended March 2021. Sales decreased by 47.97% at Rs 4.74 crore in the quarter ended March 2022 compared to Rs 9.11 crore in the previous quarter ended March 2021.
For the full year, net profit increased by 2,366.67% to Rs 2.22 crore in the year ended March 2022 from Rs 0.09 crore in the previous year ended March 2021 Sales decreased by 48.78% to Rs 21.04 crore in the year ended March 2022 from Rs 41.08 crore in the previous year ended March 2021.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues. However, we have a request.
As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.
Support quality journalism and subscribe to Business Standard.
First published: Monday, April 18, 2022. 5:23 PM IST